Home › Funds › Catalio Capital Management, LP › BMRN
Catalio Capital Management, LP position in BMRN
BIOMARIN PHARMACEUTICAL INC · Health Care
Catalio Capital Management, LP reported holding 144,971 shares of BMRN (BIOMARIN PHARMACEUTICAL INC) in its Q3 2026 13F filing — a position valued at US$8.7M, representing 1.62% of its reported portfolio and ranking #25 among its reported holdings. Catalio Capital Management, LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Catalio Capital Management, LP's BMRN position evolved
Catalio Capital Management, LP first disclosed a stake in BMRN in Q3 2026 at 144,971 shares (US$8.7M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 144.97K | $8.70M | New |
About BMRN and 13F data
BMRN (BIOMARIN PHARMACEUTICAL INC) is a Health Care company. 27 other funds we track also report a position in BMRN — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$899.3M), Viking Global Investors (US$435.8M), VIKING GLOBAL INVESTORS LP (US$430.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BMRN
- PRIMECAP MANAGEMENT CO/CA/ 14.99M sh · $899.34M · Q3 2026
- Viking Global Investors 7.62M sh · $435.82M · Q2 2026
- VIKING GLOBAL INVESTORS LP 7.17M sh · $430.39M · Q3 2026
- Deep Track Capital, LP 6.37M sh · $382.46M · Q3 2026
- Vestal Point Capital, LP 5.53M sh · $331.50M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 2.03M sh · $121.51M · Q3 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 111.50M sh · $109.58M · Q3 2026
More on Catalio Capital Management, LP
FAQ
How long has Catalio Capital Management, LP held BMRN?
Catalio Capital Management, LP has disclosed BMRN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Catalio Capital Management, LP's current position in BMRN?
As of Q3 2026, Catalio Capital Management, LP holds 144.97K shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $8.70M, representing 1.62% of its reported portfolio and ranking #25.
Has Catalio Capital Management, LP been buying or selling BMRN?
In the latest 13F filing (Q3 2026), Catalio Capital Management, LP newly opened its position in BMRN.
Which other funds hold BMRN?
Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.